Clinical Trial Update: Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update indicates that NBI-1117570 is being evaluated in inpatient adults with schizophrenia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• NBI-1117570

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Schizophrenia | Phase 2 | Status: RECRUITING